Add BrightSurf on Google Email

The Lancet


Improving blood safety worldwide

A global struggle to provide adequate and safe blood supplies in the developing world is highlighted by The Lancet Editorial. Many countries are making progress in implementing strategies to reduce unnecessary transfusions, test for compatibility, and establish voluntary donor programs.

SourceThe Lancet_DELETED·JournalThe Lancet·DateAug 2, 2007

Polar expeditions -- Bad and good for the mind

People on polar expeditions often experience disturbed sleep, impaired cognitive ability, and interpersonal tension. However, many also report feelings of camaraderie, mutual support, and personal achievement, highlighting the complex impact of these extreme environments on mental health.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJul 25, 2007

Health-care providers could help avert depression in fathers of children with fatal cancer

A study published in The Lancet Oncology found that parents' intellectual and emotional awareness time of their child's impending death is strongly associated with future health outcomes. Healthcare providers can play a crucial role in reducing long-term depression, employment issues, and psychological problems by providing adequate in...

SourceThe Lancet_DELETED·JournalThe Lancet Oncology·DateJul 20, 2007

Tiny brain, normal life

A 44-year-old man with a tiny brain and massive ventricular enlargement led a normal life despite mild leg weakness and cognitive impairments. He underwent various treatments, including shunt insertions and neuroendoscopic procedures, to manage his symptoms.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJul 19, 2007

Mental health: Neglected in the UK

UK mental health wards are criticized for being counter-therapeutic and unsafe, while a survey shows fewer people in England favor more tolerance towards mental illness. The Lancet editorial highlights the need for a substantial shift in public and ministerial attitudes to address these issues.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJul 12, 2007

Pre-exposure prophylaxis for HIV infection

Several phase II and III trials investigate anti-retroviral drug combinations for pre-exposure prophylaxis among at-risk populations. The implementation of such a program requires careful planning and substantial resources to ensure access, minimize risk behavior, and prevent drug-resistant strains.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJul 5, 2007

Stopping the HIV pandemic in children

Early HIV testing for exposed infants can prevent infection before AIDS or death, allowing for prophylaxis or treatment implementation. Universal availability of prophylaxis or treatment is crucial, but poses challenges such as long-term toxic effects of anti-retroviral treatment.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJul 5, 2007

Challenges to development of an AIDS vaccine

HIV's uniformly fatal outcome and absence of natural immunity pose significant hurdles for vaccine design. The authors call for increased funding for research and clinical trials to address these challenges and accelerate progress in finding an effective AIDS vaccine.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJul 5, 2007

Stem cell therapy to prevent heart attacks

Researchers explored the use of autologous cells derived from bone marrow cells (BMC) to strengthen cardiac function and prevent heart attacks. The study found a significant reduction in clinical events, including death, heart attack, or revascularization, in patients who received BMC infusion compared to placebo.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJun 28, 2007

Gene therapy for Parkinson's disease

A study published in The Lancet found that gene therapy can safely alleviate symptoms of Parkinson's disease, with significant improvements seen in movement and motor scores. The treatment involves injecting genetic information directly into brain cells, eliminating the need for indwelling hardware associated with deep-brain stimulation.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJun 21, 2007

Ovarian cancer is not a symptomless killer

Recent evidence shows ovarian cancer is preceded by symptoms like gastrointestinal or urinary issues in three to four months before diagnosis. Patient groups urge women to seek medical attention for new and persistent symptoms, while experts acknowledge the need for clinical judgement and more research funding.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJun 21, 2007

Neuroblastoma -- The way ahead

Researchers discuss future directions in neuroblastoma treatment, including new approaches for high-risk patients and the development of an international classification system. Current regimens and prognosis are also analyzed, highlighting the need for improved understanding of genomic alterations to guide therapy.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJun 21, 2007

27-year wait for symptoms

A woman's symptoms of colitis emerged 27 years after she left the country where she was infected with a parasitic worm. Analysis revealed larvae of Strongyloides stercoralis caused her digestive issues, highlighting the importance of considering this rare disease in patients with cellular immune defects.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJun 14, 2007